氨基糖化物:关于指示,剂量和监测的最新情况
Hazel Moore1,2,3,4,5,6, Daniel Yeoh1,2,3,4,5,6, Carly Hughes1,2,3,4,5,6
1Therapeutic Guidelines Limited, Melbourne.
Australian prescriber
|August 27, 2025
概括
澳大利亚的新指导方针强调在成人中使用氨基甘油剂时要保持瘦身. 治疗药物监测对于超过48小时的治疗至关重要,重点是曲线下的区域.
科学领域:
- 药理学
- 传染性疾病
- 临床治疗方法
背景情况:
- 氨基糖化物 (丁胺,托布拉米,阿米卡) 是严重的格拉姆阴性感染的关键肠道抗生素.
- 这些抗生素在澳大利亚具有快速杀菌作用和低耐药率.
- 最近对抗生素治疗的指导方针进行了更新.
研究的目的:
- 概述澳大利亚使用氨基糖的最新指南.
- 详细说明最佳的剂量策略和药物选择.
- 为临床医生提供关于治疗格兰氏阴性感染的新建议.
主要方法:
- 对治疗指南的审查和更新:抗生素 (2025年3月).
- 添加了针对成人氨基糖类剂量的新建议.
- 开发剂量调整计算器
主要成果:
- 成人的氨基甘油剂量现在是基于瘦身体重.
- 有计算器可用于精确的剂量计算.
- 建议在超过48小时的治疗期间对药物进行治疗监测.
结论:
- 更新的指导方针提供了最佳的氨基糖类剂量和选择策略.
- 瘦身体重是建议成年人服用的基础.
- 在延长的氨基糖化物治疗中建议监测度-时间曲线下的区域.
相关概念视频
Renal Failure: Dose Adjustments
153
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
153
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
Acute Pyelonephritis II: Diagnostic Studies and Management
40
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
40
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.7K
Heart Failure Drugs: Inotropic Agents
717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717


